Skip to main content

Month: June 2020

SpringWorks Therapeutics Announces Dosing of First Patient in Phase 1b Combination Study Evaluating Nirogacestat and GlaxoSmithKline’s Belantamab Mafodotin for the Treatment of Relapsed or Refractory Multiple Myeloma

STAMFORD, Conn., June 22, 2020 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that the first patient has been dosed in a Phase 1b clinical trial evaluating SpringWorks Therapeutics’ investigational gamma secretase inhibitor, nirogacestat, in combination with GlaxoSmithKline’s (GSK) investigational anti-B-cell maturation antigen (BCMA) antibody-drug conjugate, belantamab mafodotin, in patients with relapsed or refractory multiple myeloma. The nirogacestat and belantamab mafodotin combination is being evaluated as a sub-study in GSK’s ongoing DREAMM-5 platform trial.Gamma secretase inhibition prevents the cleavage and shedding of BCMA from the surface of myeloma...

Continue reading

ARMOUR Residential REIT, Inc. Raises Monthly Common Dividend Guidance to $0.10 per Share for the Third Quarter of 2020

VERO BEACH, Florida, June 22, 2020 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced guidance on monthly cash dividends for the Company’s Common Stock for the third quarter. Based on its current financial position and outlook, the Company anticipates declaring dividends early in each month as follows:Third Quarter 2020 Common Stock Dividend GuidanceJune 2020 DividendsARMOUR previously announced the resumption of monthly dividends for its Common Stock with a $0.09 cash dividend per share payable on June 29, 2020 to holders of record as of June 15, 2020. The monthly cash dividend on the Company’s 7.00% Series C Preferred Stock in the amount of $0.14583 is also payable on June 29, 2020 to holders of record on June 15, 2020.Certain Tax MattersARMOUR has elected to be...

Continue reading

Descartes helps Customers Adapt to COVID-19 Supply Chain Disruptions using Microsoft Azure

WATERLOO, Ontario, June 22, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that, as a global partner, it is collaborating with Microsoft to help customers adapt to COVID-19–related logistics and supply chain disruptions by leveraging their Descartes solutions.Descartes has recently highlighted several customers in diverse industries who have used Descartes’ cloud-based solutions to respond innovatively and swiftly to volatile market conditions and new demands on their operations:Capital Logistics Uses Descartes Solutions to Help National Grocery Retailers Facing COVID-19–Driven VolatilityANCLA Logistik Helps Ecommerce Retailers Impacted by COVID-19 Fulfillment Disruptions with Descartes’ Ecommerce Warehouse Management (WMS)...

Continue reading

Steamboat Hills Geothermal Power Plant Enhancement in Nevada Begins Commercial Operation

RENO, Nev., June 22, 2020 (GLOBE NEWSWIRE) — Ormat Technologies Inc. (NYSE: ORA) announced that the enhancement of its Steamboat Hills geothermal power plant located near Reno, Nevada is complete and achieved commercial operation on June 6, 2020. Enhancement work included the replacement of all old generating unit equipment with new, state-of-the-art equipment and resource modifications that increased the generating capacity of the Steamboat complex by approximately 19 MW to a total of 84 MW. The new equipment will increase the productivity and efficiency of the power plant and is expected to reduce maintenance costs per kWh.The Steamboat Hills power plant continues to sell its electricity under the current 25-year long term portfolio power purchase agreement with Southern California Public Power Authority (SCPPA), with 100% of...

Continue reading

Eramet: response to rumours about its subsidiary Aubert & Duval

Paris, 22 June 2020, 12:00 pmPRESS RELEASEEramet: response to rumours about its subsidiary Aubert & DuvalFollowing a press release this morning, Eramet group would like to provide some details as follows.The current crisis due to Covid-19 is unprecedented, with a lasting impact on the global economy. The very significant slowdown of the aerospace sector weighs strongly on the activity of Aubert & Duval (“A&D”), Eramet’s subsidiary. The decrease in the production rates of the aerospace industry, notably Airbus which announced an approximately one-third cut in production versus pre-crisis level, should indeed have a strong and lasting impact on A&D’s activity. Aerospace sales account for more than 70% of the subsidiary’s turnover.A&D’s sites are facing a strong slowdown, and the production rate of each workshop...

Continue reading

Eramet : réponse aux rumeurs concernant sa filiale Aubert & Duval

Paris, le 22 juin 2020, 12h00COMMUNIQUE DE PRESSEEramet : réponse aux rumeurs concernant sa filiale Aubert & DuvalA la suite de la parution d’un article de presse ce matin, le groupe Eramet tient à apporter les précisions suivantes.La crise actuelle survenue avec l’apparition du Covid-19 est sans précédent et touche durablement l’économie mondiale. Le très fort ralentissement du secteur aéronautique pèse significativement sur l’activité d’Aubert & Duval (« A&D »), filiale d’Eramet. La baisse des cadences de production dans l’industrie aéronautique, notamment Airbus qui a annoncé un recul d’environ un tiers par rapport au niveau d’avant crise, devrait en effet impacter fortement et durablement l’activité d’A&D, dont les ventes aéronautiques représentent plus de 70 % du chiffre d’affaires.Les sites d’A&D connaissent...

Continue reading

Burning Rock Announces Full Exercise of Over-Allotment Option in Initial Public Offering

GUANGZHOU, China, June 22, 2020 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (“Burning Rock” or the “Company”) (NASDAQ: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that the underwriters of its initial public offering (the “IPO”) fully exercised their over-allotment option to purchase an additional 2,025,000 American Depositary Shares (“ADSs”), each representing one Class A ordinary share, of the Company at the IPO price of US$16.50 per ADS. After giving effect to the full exercise of the over-allotment option, the aggregate offering size of the IPO and the concurrent private placement to Lake Bleu Prime Healthcare Master Fund Limited is approximately US$281.2 million. The Company’s total number of ordinary shares (including ordinary...

Continue reading

Bone Void Fillers Market Size to Reach USD 3.90 Billion by 2027; Owing to Increasing Prevalence of Bone-Associated Disease, says Fortune Business Insights™

Pune, June 22, 2020 (GLOBE NEWSWIRE) — The global bone void fillers market size is expected to exhibit exponential growth owing to the increasing prevalence of bone-associated disease across the globe. Fortune Business Insights, published this information in its latest report, titled “Bone Void Fillers Market Size, Share & Industry Analysis, By Type (Demineralized Bone Matrix (DBM), Collagen Matrix, Calcium Sulfate, Tri-calcium Phosphate, and Others), By Form (Gel, Granules, Paste, Putty, and Others), By End User (Hospitals, Specialty Clinics and Others), and Regional Forecast, 2020-2027.” The report mentions that the market is likely to generate USD 3.90 billion by 2027, while exhibiting a CAGR of 5.4% between 2020 and 2027. Furthermore, the report observes that the market was worth USD 2.80 billion in 2019.Bone void fillers...

Continue reading

Cinedigm and Glass House Distribution Kick Off a Multi-Film Deal With the Gritty Drama GUTTERBUG

LOS ANGELES, June 22, 2020 (GLOBE NEWSWIRE) — Cinedigm Corp. (NASDAQ: CIDM) has announced a multi-film deal with Glass House Distribution starting with GUTTERBUG.  Directed by Andrew Gibson, the award-winning film is scheduled to release on Digital and DVD on August 11. 2020. The partnership between Cinedigm and Glass House Distribution also includes the release of comedy CANADIAN STRAIN and thriller SAVIORS, both scheduled to release in September.GUTTERBUG’s cast of Andrew Yackel (“Mindhunter”), Justin Pietropalo (Masters), and Hannah Mosqueda (“James Patterson’s Murder Is Forever”) star in this counterculture anthem about a young man grappling with homelessness and mental health within his drug fueled reality.GUTTERBUG takes a dirty dive into the realities of American drug culture where the road to hell is paved with good intentions....

Continue reading

DSV, 832 – MAJOR SHAREHOLDER ANNOUNCEMENT

Company Announcement No. 832Pursuant to section 30 of the Danish Capital Markets Act it is hereby announced that WCM Investment Management, LLC, Laguna Beach, USA has informed DSV Panalpina A/S that WCM Investment Management has increased its holding of shares and other financial instruments with similar economic effect in DSV Panalpina A/S to 11,751,742 shares, corresponding to 5.1% of the entire share capital and voting rights.Any questions may be addressed to Executive Vice President, Investor Relations, Flemming Ole Nielsen, tel. +45 43 20 33 92.Yours sincerely,DSV Panalpina A/SAttachment832 – Announcement (22.06.2020) – Major shareholder announcement

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.